Diarrhea associated with weight loss injections likely results from multiple factors, though the precise mechanisms are not fully understood
Within the findings were several considerations for patients and payers: High costs for GLP-1 medications ranked as respondents top concern (followed by lack of control over who is prescribed the medications) 93% covered GLP-1s for management of diabetes in the previous plan year
Nat Commun 15:4548 Wharton S, Calanna S, Davies M et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between Gastrointestinal adverse events and weight loss
Who May Benefit vs Who Should Avoid Potential candidates for glutathione injections include individuals with mild to moderate hyperpigmentation seeking gradual improvement, those committed to long-term maintenance treatments, and patients who have thoroughly discussed risks with qualified medical providers
The FDA has issued multiple rounds of warning letters to telehealth companies regarding marketing practices for compounded GLP-1 products
The list goes on and on of crafty ways companies spin alternative forms of ingredients to try to sell them
